News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,741 Results
Type
Article (39639)
Company Profile (247)
Press Release (657855)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204137)
Career Advice (2007)
Deals (35414)
Drug Delivery (95)
Drug Development (81033)
Employer Resources (172)
FDA (16171)
Job Trends (14851)
News (345132)
Policy (32530)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49414)
ALS (86)
Alzheimer's disease (1371)
Antibody-drug conjugate (ADC) (120)
Approvals (16174)
Artificial intelligence (242)
Autoimmune disease (21)
Automation (15)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (104)
Biotechnology (175)
Bladder cancer (63)
Brain cancer (26)
Breast cancer (270)
Cancer (2134)
Cardiovascular disease (170)
Career advice (1674)
Career pathing (29)
CAR-T (145)
Cell therapy (406)
Cervical cancer (19)
Clinical research (65890)
Collaboration (811)
Compensation (518)
Complete response letters (19)
COVID-19 (2583)
CRISPR (37)
C-suite (230)
Cystic fibrosis (100)
Data (2086)
Decentralized trials (2)
Denatured (17)
Depression (41)
Diabetes (262)
Diagnostics (6354)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (119)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86393)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112023)
Executive appointments (705)
FDA (17375)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (730)
Gene editing (100)
Generative AI (19)
Gene therapy (286)
GLP-1 (702)
Government (4409)
Grass and pollen (4)
Guidances (51)
Healthcare (18812)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (110)
Indications (28)
Infectious disease (2723)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (92)
Interviews (311)
IPO (16498)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (10)
Labor market (36)
Layoffs (461)
Leadership (16)
Legal (7908)
Liver cancer (72)
Lung cancer (307)
Lymphoma (145)
Machine learning (5)
Management (58)
Manufacturing (292)
MASH (63)
Medical device (13353)
Medtech (13358)
Mergers & acquisitions (19441)
Metabolic disorders (666)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (83)
Neuropsychiatric disorders (26)
Neuroscience (1883)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2573)
Now hiring (38)
Obesity (358)
Opinion (204)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (227)
Patient recruitment (104)
Peanut (46)
People (57244)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20516)
Phase II (29015)
Phase III (21627)
Pipeline (1128)
Policy (132)
Postmarket research (2563)
Preclinical (8681)
Press Release (64)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (373)
Real estate (5906)
Recruiting (65)
Regulatory (22221)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (126)
Series B (81)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2209)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (28)
The Weekly (28)
United States (22301)
Vaccines (670)
Venture capitalists (40)
Weight loss (231)
Women's health (34)
Worklife (15)
Date
Today (179)
Last 7 days (538)
Last 30 days (2435)
Last 365 days (32896)
2025 (9634)
2024 (35221)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54084)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (37790)
Australia (6179)
California (5872)
Canada (1958)
China (499)
Colorado (258)
Connecticut (265)
Delaware (138)
Europe (81085)
Florida (870)
Georgia (202)
Idaho (57)
Illinois (517)
India (25)
Indiana (304)
Iowa (10)
Japan (155)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (867)
Massachusetts (4387)
Michigan (216)
Minnesota (383)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1672)
New Mexico (28)
New York (1680)
North Carolina (945)
North Dakota (7)
Northern California (2573)
Ohio (199)
Oklahoma (14)
Oregon (33)
Pennsylvania (1321)
Puerto Rico (11)
Rhode Island (32)
South America (1096)
South Carolina (21)
South Dakota (1)
Southern California (2209)
Tennessee (100)
Texas (874)
Utah (173)
Virginia (139)
Washington D.C. (60)
Washington State (540)
West Virginia (3)
Wisconsin (51)
697,741 Results for "tricida inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Tricida Provides Strategic Update
Tricida, Inc., announced that the Board of Directors has authorized Tricida to initiate a review of strategic alternatives to maximize stakeholder value.
November 2, 2022
·
3 min read
Business
Tricida Announces Third Quarter 2022 Financial Results
Tricida, Inc. announced financial results for the three and nine months ended September 30, 2022 and provided an update on key initiatives.
November 14, 2022
·
9 min read
Biotech Bay
Tricida Announces $125 Million Debt Facility with Hercules Capital
Tricida, Inc. announced that it has entered into a debt facility with Hercules Capital, Inc., a leader in customizing debt financing for companies in the life sciences and technology-related markets.
October 19, 2022
·
4 min read
Drug Development
Reeling from CKD Flop, Tricida Downsizes by Nearly 60%
Tricida, Inc. is reducing its headcount by around 57% to improve its financial standing after its lead candidate failed in a Phase III trial, the company revealed in its third-quarter financial results.
November 16, 2022
·
2 min read
·
Tristan Manalac
Biotech Bay
Tricida to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Tricida, Inc. announced that it will present at the H.C. Wainwright 24th Annual Global Investment Conference. Tricida will provide a company overview, business update and progress on the company’s key initiatives.
September 6, 2022
·
1 min read
Business
Tricida Announces Second Quarter 2022 Financial Results
Tricida, Inc. announced financial results for the three and six months ended June 30, 2022 and provided an update on key initiatives.
August 8, 2022
·
10 min read
Drug Development
Tricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of Veverimer
Tricida, Inc. (NASDAQ: TCDA) announced today the top-line results from its VALOR-CKD renal outcomes clinical trial, designed to evaluate veverimer’s ability to slow CKD progression in patients with metabolic acidosis and chronic kidney disease (CKD).
October 24, 2022
·
9 min read
Business
Tricida Announces First Quarter 2022 Financial Results
Tricida, Inc. announced financial results for the three months ended March 31, 2022 and provided an update on key initiatives.
May 10, 2022
·
9 min read
Drug Development
Tricida Stocks Plummet Following Trial Failure in Kidney Disease
Top-line data from Tricida’s VALOR-CKD trial showed veverimer failed to meet its primary endpoint and does not slow progression in patients with metabolic acidosis and CKD.
October 24, 2022
·
2 min read
·
Tristan Manalac
Business
Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Monday, August 8, 2022
Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its second quarter 2022 financial results after the close of market on Monday, August 8, 2022.
August 1, 2022
·
1 min read
1 of 69,775
Next
